Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus

Nov. 28, 2011

Novartis obtains approval in Japan for new indication for Sandostatin LAR

Nov. 28, 2011

Mibefradil dihydrochloride given with temozolomide in murine glioma model

Nov. 28, 2011

Iressa approved in Japan in new lung cancer indication

Nov. 25, 2011

U.S. university team prepares new ether-based compounds

Nov. 25, 2011

New CYP17 inhibitors for cancer disclosed by Bristol-Myers Squibb

Nov. 25, 2011

Researchers at Deciphera Pharmaceuticals present novel tyrosine-protein kinase inhibitors

Nov. 25, 2011

Additional dosage and indication approved for Herceptin in Japan

Nov. 25, 2011

Preclinical and clinical results reported for Myrexis oncolytic compounds

Nov. 25, 2011

Melphalan flufenamide evaluated in phase I/IIa study

Nov. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.